Azenta (AZTA) Stock Price, News & Analysis

Company Overview

Azenta, Inc. (NASDAQ: AZTA) is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical and biotechnology companies, academic and government research institutions, clinical research organizations, and other laboratories.

The company’s products include automated sample storage systems, laboratory automation equipment, sample-management software, consumables, and cold-storage solutions designed to preserve and track biological materials. Azenta also provides genomics and related laboratory services, including next-generation sequencing, genotyping, and other analytical services used in research, drug development, and clinical applications.

Azenta was formerly known as Brooks Automation and adopted its current name in 2021 as the company focused on life sciences. It serves customers internationally through operations and facilities across North America, Europe, and Asia. Its business is organized around life sciences products and life sciences services, with an emphasis on improving the reliability, traceability, and efficiency of sample-based research.

Key Stats

• Today's Range: $36.57 to $37.99
• 50-Day Range: $29.88 to $42.73
• 52-Week Range: $15.93 to $46.41
• Volume: 1.04 million shs
• Average Volume: 943,245 shs
• Market Capitalization: $1.65 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $41.20
• Consensus Rating: Hold

Azenta Stock Analysis - MarketRank™

Azenta scored higher than 31% of companies evaluated by MarketBeat, and ranked 764th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Hold

Consensus Rating

Azenta has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on no strong buy ratings, 4 buy ratings, 2 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Azenta is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Azenta has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Azenta is -13.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Azenta is -13.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Azenta has a P/B Ratio of 1.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

13.63% of the float of Azenta has been sold short.

Short Interest Ratio / Days to Cover

Azenta has a short interest ratio ("days to cover") of 6.12.

Change versus previous month

Short interest in Azenta has recently decreased by 1.18%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Azenta does not currently pay a dividend.

Dividend Growth

Azenta does not have a long track record of dividend growth.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.33

News Sentiment

Azenta has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for Azenta this week, compared to 3 articles on an average week.

MarketBeat Follows

1 people have added Azenta to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Azenta insiders have bought more of their company's stock than they have sold. Specifically, they have bought $8,097.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

10.90% of the stock of Azenta is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

99.08% of the stock of Azenta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 10/12/2026
• Next Earnings (Estimated): 11/20/2026
• Fiscal Year End: 9/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:AZTA
• CIK: 933974
• Web: www.azenta.com
• Phone: (978) 262-2400
• Fax: 978-262-2500
• Employees: 3,000
• Year Founded: 1978

Price Target and Rating

• Average Price Target for Azenta: $41.20
• High Price Target: $45.00
• Low Price Target: $37.00
• Potential Upside/Downside: +9.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.43
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.76)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$55.76 million
• Net Margins: -20.63%
• Pretax Margin: -24.81%
• Return on Equity: 1.18%
• Return on Assets: 0.97%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.50
• Quick Ratio: 2.21

Sales & Book Value

• Annual Sales: $593.82 million
• Price / Sales: 2.79
• Cash Flow: $1.81 per share
• Price / Cash Flow: 20.81
• Book Value: $37.67 per share
• Price / Book: 1.00

Miscellaneous

• Outstanding Shares: 43,810,000
• Free Float: 39,033,000
• Market Cap: $1.65 billion
• Optionable: Optionable
• Beta: 1.52